Journal of Hebei University (Natural Science Edition) ›› 2018, Vol. 38 ›› Issue (6): 610-616.DOI: 10.3969/j.issn.1000-1565.2018.06.009

Previous Articles     Next Articles

Preparation and pharmacokinetics of aripiprazole long-acting injectable suspension

LI Xin,LIU Haofan,YANG Han,ZHAO Na,ZHANG Donghao,HU Liandong   

  1. Key Laboratory of Pharmaceutical Quality Control of Hebei Province, College of Pharmacy, Hebei University, Baoding 071002, China
  • Received:2018-02-25 Online:2018-11-25 Published:2018-11-25

Abstract: To prepare aripiprazole long-acting injectable suspension and study its pharmacokinetics in rabbits. Suspension was prepared by high-pressure homogenization and the product was obtained after freeze-drying; The concentration of drug in plasma was determined by high performance liquid chromatography. The long-acting injectable suspension formulation obtained was uniform and stable in particle size and had no significant irritation to animal tissues. The in vivo pharmacokinetics results showed that the long-acting injection has a good sustained-release effect in vivo and can be sustainedly released for 15 days. Aripiprazole long-acting injectable suspension have controllable quality and can be released continuously and steadily, which is expected to provide a convenient, safe and effective new dosage form for schizophrenic patients.

Key words: schizophrenia, aripiprazole, long-acting suspension, intramuscular injection, pharmacokinetics

CLC Number: